TAMOXIFEN
Strength20 mg
Formoral.solid
10-20 mg once daily for 3-6 months for painful, recent-onset (<6 months) glandular gynaecomastia x 3-6 months
Specialist pediatric/adolescent endocrinology evaluation
Tamoxifen 20 mg Tablets SmPC sections 4.1-4.4 (eMC product 12524)
Selective oestrogen-receptor modulator that blocks oestrogen's proliferative effect on glandular breast tissue, used for painful, recent-onset gynaecomastia once secondary causes such as drug-induced, testicular, hepatic, or hypogonadal causes have been excluded.
- First exclude secondary causes: drug-induced (spironolactone, digoxin, finasteride), testicular tumor, hepatic failure, or hypogonadism.
- Pubertal gynaecomastia is physiological and usually resolves spontaneously within 1-2 years without medical therapy.
- Gynaecomastia is not a licensed indication. The label covers breast cancer, its prevention, and ovulation induction - nothing else. This is an off-label use with reasonable evidence behind it, but say so.
- Two to three times the clot risk. Stop it at least six weeks before planned surgery or any long stretch of immobility.
- There is an increased risk of deep vein thrombosis and thromboembolism.
| Egyptian brand | Manufacturer | Indicative price |
|---|---|---|
| TAMOXIFEN 20 MG 20 TABS. | TECHNOPHARMA | 68.00 EGP (3.40/unit) |